Thirteen CTP class B patients were reclassified as IGF/CTP-C (BC) and had a median OS of 4.18 (95% CI, 2.07 months-N/A) and a median PFS of 3.29 months (95% CI, 2.07 months-N/A). Here, IGF1 is linked to breast cancer.